BREIJ; Esther C. W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BREIJ; Esther C. W..The latest application filed is for "bispecific antibody against cd3 and cd20 in combination therapy for treating follicular lymphoma".

Company Profile

8.3.15

BREIJ; Esther C. W. - Driebergen NL
BREIJ; Esther C.W - Driebergen NL
BREIJ; Esther C. W. - Utrecht NL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bispecific Antibody Against Cd3 And Cd20 In Combination Therapy For Treating Follicular Lymphoma App 20220144964 - ELLIOTT; Brian ; et al.	2022-05-12
Bispecific Antibody Against Cd3 And Cd20 In Combination Therapy For Treating Diffuse Large B-cell Lymphoma App 20220119544 - Elliott; Brian ; et al.	2022-04-21
Bispecific Antibodies Against Cd3 And Cd20 For Treating Chronic Lymphocytic Leukemia App 20220112287 - Elliott; Brian ; et al.	2022-04-14
Bispecific Antibody Against Cd3 And Cd20 In Combination Therapy For Treating Follicular Lymphoma App 20220112300 - ELLIOTT; Brian ; et al.	2022-04-14
Methods Of Treating Cancer With A Combination Of An Anti-pd-1 Antibody And An Anti-tissue Factor Antibody-drug Conjugate App 20220088191 - RANGWALA; Reshma Abdulla ; et al.	2022-03-24
Antibodies Grant 11,261,254 - Koopman , et al. March 1, 2	2022-03-01
Antibodies App 20220048999 - KOOPMAN; Louise ; et al.	2022-02-17
Antibodies App 20220049013 - SATIJN; David ; et al.	2022-02-17
Methods Of Treating Cancer With A Combination Of An Anti-vegf Antibody And An Anti-tissue Factor Antibody-drug Conjugate App 20210402003 - RANGWALA; Reshma Abdulla ; et al.	2021-12-30
Anti-tissue Factor Antibody-drug Conjugates And Their Use In The Treatment Of Cancer App 20210308208 - RANGWALA; Reshma A. ; et al.	2021-10-07
Antibodies Grant 11,130,819 - Satijn , et al. September 28, 2	2021-09-28
Antibodies App 20210292418 - KOOPMAN; Louise ; et al.	2021-09-23
Antibodies App 20210230296 - SATIJN; David ; et al.	2021-07-29
Antibodies Grant 11,008,399 - Satijn , et al. May 18, 2	2021-05-18
Methods Of Treating Cancer With A Combination Of An Anti-pd-1 Antibody And An Anti-tissue Factor Antibody-drug Conjugate App 20210107980 - RANGWALA; Reshma Abdulla ; et al.	2021-04-15
Antibodies App 20210070877 - SATIJN; David ; et al.	2021-03-11
Methods Of Treating Cancer With A Combination Of A Platinum-based Agent And An Anti-tissue Factor Antibody-drug Conjugate App 20210015939 - RANGWALA; Reshma Abdulla ; et al.	2021-01-21
Antibodies App 20200277397 - SATIJN; David ; et al.	2020-09-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.